![]() ![]() G01N2333/745- Assays involving non-enzymic blood coagulation factors.G01N2333/435- Assays involving biological materials from specific organisms or of a specific nature from animals from humans.G01N2333/00- Assays involving biological materials from specific organisms or of a specific nature.blood, urine Testing involving biospecific ligand binding methods Immunological testing involving blood coagulating time or factors, or their receptors G01N33/86- Chemical analysis of biological material, e.g.blood, urine Testing involving biospecific ligand binding methods Immunological testing G01N33/50- Chemical analysis of biological material, e.g.G01N33/00- Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00.G01N- INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Buren Philpot V Jun filed Critical Buren Philpot V Jun Priority to US06/459,494 priority Critical patent/US4461830A/en Priority to PCT/US1984/000061 priority patent/WO1984002982A1/en Priority to EP19840900787 priority patent/EP0131625A4/en Priority to CA000445500A priority patent/CA1218001A/en Priority to US06/609,817 priority patent/US4567137A/en Application granted granted Critical Publication of US4461830A publication Critical patent/US4461830A/en Anticipated expiration legal-status Critical Status Expired - Fee Related legal-status Critical Current Links Original Assignee Buren Philpot V Jun Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Expired - Fee Related Application number US06/459,494 Inventor Van B. Google Patents Serum fibrinogen viscosity in clinical medicineÄownload PDF Info Publication number US4461830A US4461830A US06/459,494 US45949483A US4461830A US 4461830 A US4461830 A US 4461830A US 45949483 A US45949483 A US 45949483A US 4461830 A US4461830 A US 4461830A Authority US United States Prior art keywords serum viscosity fibrinogen predetermined solution Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US4461830A - Serum fibrinogen viscosity in clinical medicine This correlation may be useful for anticipating the need for repeat plasmapheresis.US4461830A - Serum fibrinogen viscosity in clinical medicine Serum viscosity and electrophoresis are recommended before and after plasmapheresis in order to correlate viscosity and M-spike with patient symptoms. ![]() Hyperviscosity syndrome can also occur in multiple myeloma patients.Ä«ecause the ability of a monoclonal protein to cause hyperviscosity is affected by its concentration, molecular weight, and aggregation, sera with concentrations of monoclonal IgM greater than 4 g/dL, IgA greater than 5 g/dL, or IgG greater than 6 g/dL should be tested for hyperviscosity. The most common cause of serum hyperviscosity is the presence of large concentrations of IgM monoclonal proteins, and Waldenstrom macroglobulinemia accounts for 80% to 90% of hyperviscosity cases. Funduscopic examination reveals dilation of retinal veins and flame shaped retinal hemorrhages. Hyperviscosity may be manifested by nasal bleeding, blurred vision, headaches, dizziness, nystagmus, deafness, diplopia, ataxia, paresthesias, or congestive heart failure. Viscosity is the property of fluids to resist flow. Critical Laboratory Values - Mid Coast Hospital.Critical Laboratory Values - Memorial NH.Critical Laboratory Values - Scarborough & MMC.System-Wide MaineHealth Laboratory Critical Values.Laboratory Corporation of America (LabCorp) Test Menu.Top 3 Reference Laboratory Test Catalogs for Miscellaneous Lab Test Orders: Biotin Interference Thresholds-non-Scarborough sites.Biotin Interference Thresholds-Scarborough site.Individually Orderable IGE Allergens Chart with Test Codes.Tick-Bourne Disease Pathogen Testing Information.Scarborough NorDx Urine Toxicology Guide.2022 Acceptable Alternate Tube Types for Chemistry.2022 Acceptable Tan Top Usage for Hematology.NorDx Respiratory Panel Quick Guide (MidCoast only).NorDx Respiratory Panel Quick Guide (non MidCoast).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |